HealthDay News For patients with newly diagnosed breast cancer, tailored strategies for implementation of routine depression screening result in a greater proportion of referrals to behavioral care, according to a study published in the Jan. 4 issue of the Journal of the American Medical Association.

Eric E. Hahn, Ph.D., M.P.H., from Kaiser Permanente Southern California in Pasadena, and colleagues examined the effectiveness of an implementation strategy-guided depression screening program in a trial conducted at 6 medical centers with 1,436 patients diagnosed with new primary breast cancer. The centers were randomly assigned to either tailored implementation strategies (3 sites; 744 patients) or education-only (3 sites; 692 patients). The program consisted of 9-item Patient Health Questionnaire screening and algorithm-based scoring and referral to behavioral health services; at tailored intervention sites, clinical teams received program education, audit, and feedback of performance data and implementation facilitation.

The researchers found that 7.9 and 0.1% of patients at tailored sites and education-only sites, respectively, were referred. Referrals to a behavioral health clinician were completed by 44 of 59 (75%) and 1 of 1 patient at the intervention and education-only sites, respectively. Patients at tailored sites had significantly fewer outpatient visits in medical oncology in adjusted models (rate ratio, 0.86); no differences were seen in utilization of primary care, urgent care, or emergency department visits.

Continue Reading

“Tailored strategies for implementation of routine depression screening compared with an education-only control group resulted in a greater proportion of referrals to behavioral care,” the authors write. “Further research is needed to understand the clinical benefit and cost-effectiveness of this program.”

Abstract/Full Text (subscription or payment may be required)